The ROE (Return on Equity) of Cannassure Therapeutics Ltd (CSURE.TA) is 22.13%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2022-12-31 | 22.13% |
| 2021-12-31 | -325.35% |
| 2020-12-31 | -259.10% |
| 2019-12-31 | -72.62% |
| 2018-12-31 | -106.83% |
| 2017-12-31 | -6.68% |
| 2016-12-31 | -37.50% |
| 2015-12-31 | -109.03% |
| 2014-12-31 | 22.13% |